.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Medtronic
Johnson and Johnson
UBS
Dow
Chinese Patent Office
QuintilesIMS
Julphar
Fish and Richardson

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065381

« Back to Dashboard
NDA 065381 describes CEFPROZIL, which is a drug marketed by Ranbaxy Labs Ltd, Teva, Apotex Inc, Wockhardt, Sandoz, Teva Pharms, Aurobindo Pharma Ltd, Lupin, Orchid Hlthcare, and Aurobindo Pharma, and is included in fifteen NDAs. It is available from nineteen suppliers. Additional details are available on the CEFPROZIL profile page.

The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cefprozil profile page.

Summary for NDA: 065381

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 065381

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFPROZIL
cefprozil
FOR SUSPENSION;ORAL 065381 ANDA NorthStar Rx LLC 16714-396 16714-396-01 50 mL in 1 BOTTLE (16714-396-01)
CEFPROZIL
cefprozil
FOR SUSPENSION;ORAL 065381 ANDA NorthStar Rx LLC 16714-396 16714-396-02 75 mL in 1 BOTTLE (16714-396-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength125MG/5ML
Approval Date:Jan 30, 2007TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength250MG/5ML
Approval Date:Jan 30, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
McKinsey
AstraZeneca
Chinese Patent Office
Boehringer Ingelheim
US Department of Justice
Fish and Richardson
Federal Trade Commission
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot